HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Extract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ward, H. Search for Related Content PubMed Articles by Ward, H. Topic Collections Related Articles

Brief Encounters

MAGIC BULLETS
The ideal for STI management has always been a cheap, single dose, and preferably oral treatment. Add to this an effective syndromic approach to diagnosis and there is the possibility of rapidly improved control of STI and consequent reduction in HIV transmission. Pépin and Mabey have reviewed the effectiveness and price of single dose treatments for various syndromes, and conclude that there is no longer any financial obstacle to the widespread use of single dose treatments. The development of generic drug industries in India and Africa has brought down the price of many drugs, including third generation cephalosporins.
See p 432

DROWNING OR WAVING?
Few practitioners in the UK would argue with the basic problem identified by Bradbeer and Mears that GUM services are "consistently overstretched". But consensus breaks down when it comes to finding solutions. The debate presented in this issue is not the first, nor, undoubtedly, the last word on this topic. Bradbeer and Mears set out possible ways of addressing the increased workload: increased throughput (abandoning consultations and examinations in asymptomatic patients, for example), reduced follow up, getting someone else to do the work (the strategy underpinning the sexual health strategy), or reducing STIs in the population. The last option is dismissed—primary prevention never produces quick fixes—and the others are discussed. Carne contests many of the proposed efficiency measures, reminding us both of the advantages of the sexual health consultation, even for asymptomatic patients, and of the lack of precision in the very concept "asymptomatic". The floor is now open for contributions.
See p 435 and 439

"I DO NOT WANT TO BE FRIENDS WITH SOMEONE WHO HAS AIDS": STIGMA AND TESTING PROGRAMMES
South Africa is experiencing a massive AIDS epidemic. A key element in the control programme is voluntary testing and counselling, but uptake remains relatively low. Kalichman and Simbayi report interviews with 500 men and women living in a black township in Cape Town. Less than half had been tested for HIV, and of those tested more than a third had not collected their results. Those who had not been tested were more likely to agree that people with AIDS are dirty and should feel ashamed and guilty. The study shows the urgent need for anti-stigma campaigns, and the authors suggest social marketing, community mobilisation, and social activism models as a way forward.
See p 442

CYBER SEX
More and more people are meeting sexual partners through the internet. In an exploratory study of men who have sex with men at a resort in the USA, Mettey and colleagues found that those who reported meeting partners on the internet had more risky sexual practices. The next step is to look at better ways of using cyber power for prevention interventions.
See p 466

Don’t forget LGV Although not often seen in Europe, Nieuwenhuis et al report a case of lymphogranuloma venereum in a man who did not report travel overseas. The patient was diagnosed with HIV at the same time, and responded well to azithromycin See p 453

LET’S LOOK HARDER
High rates of gonorrhoea transmission between men continue, yet we have relatively poor methods for diagnosing infection anywhere other than the urethra. Nucleic acid amplification tests for gonorrhoea are not licensed for rectal and pharyngeal diagnosis. Young and colleagues evaluated a ligase chain reaction (LCR) based gonorrhoea test on pharyngeal and rectal samples. The LCR picked up almost twice as many cases as culture alone, and almost a quarter of those cases were culture negative at all three sites and would therefore have been missed.
See p 484

Related Articles

Sexually transmitted infections in Africa: single dose treatment is now affordable

J Pépin and D Mabey
Sex. Transm. Inf. 2003 79: 432-434. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				R. C. Ballard, S. M. Berman, K. A. Fenton, R. F. Savaris, A. M. Abeche, J. D. Klausner, R. P. Kohn, C. K. Kent, G. Riedner, H. Grosskurth, et al. Azithromycin versus Penicillin for Early Syphilis N. Engl. J. Med., January 12, 2006; 354(2): 203 - 205. [Full Text] [PDF]

				M Romoren, M Rahman, J Sundby, and P Hjortdahl Chlamydia and gonorrhoea in pregnancy: effectiveness of diagnosis and treatment in Botswana Sex. Transm. Inf., October 1, 2004; 80(5): 395 - 400. [Abstract] [Full Text] [PDF]

				J Pepin, S Deslandes, N Khonde, D F Kintin, S Diakite, M Sylla, H Meda, F Sobela, C Asamoah-Adu, T Agyarko-Poku, et al. Low prevalence of cervical infections in women with vaginal discharge in west Africa: implications for syndromic management Sex. Transm. Inf., June 1, 2004; 80(3): 230 - 235. [Abstract] [Full Text] [PDF]

This Article Extract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ward, H. Search for Related Content PubMed Articles by Ward, H. Topic Collections Related Articles